Dr. David N. Bailey: Analytical Toxicology; Drug Binding; Drug Metabolism

David Bailey

David N. Bailey, M.D.
Distinguished Research Professor (Pathology and Pharmacy)
Emeritus Professor of Pathology
Deputy Dean, Skaggs School of Pharmacy and Pharmaceutical Sciences
Vice Chair for Education (Pathology)

Telephone (Office):
(858) 822-5551
Email:
dnbailey@ucsd.edu

Research Summary: Analytical Toxicology, Drug Binding, and Drug Metabolism

Dr. Bailey's research has focused on development of analytical methodology for measuring drugs and drug metabolites; on the binding of drugs to human tissues; and on the percutaneous absorption of drugs with particular emphasis on psychotropic drugs and drugs of abuse.

Academic Achievements

Education: B.S in Chemistry (1967) Indiana University; M.D. (1973) Yale; Postdoctoral Fellow (1973-1975) and Resident (1975-1977) Yale.

Leadership Experience: Chair, Dept. of Pathology UCSD (1986-2001); Interim Vice Chancellor for Health Sciences and Dean, School of Medicine UCSD (1999-2000 and 2006-07); Deputy Vice Chancellor for Health Sciences and Dean, Faculty and Student Matters UCSD (2001-2006); Vice Chancellor for Health Affairs and Dean, School of Medicine UCI (2007-2009); Deputy Dean, Skaggs School of Pharmacy & Pharm. Sci. UCSD (2010 – present); Vice Chair for Education (Pathology) UCSD (2010 - present); President, California Association of Toxicologists (1981-1982); President, Academy of Clinical Laboratory Physicians & Scientists (1988-1989); Secretary-Treasurer, Association of Pathology Chairs (1996-1999).

Teaching

  • Clinical pathology (Laboratory Medicine) lectures, laboratories, and seminars, for medical students
  • Clinical pathology lectures and conferences for pathology residents

Key Contributions to Pharmaceutical Sciences

  • Reported the binding of cocaethylene and other cocaine homologs to human serum proteins and tissues
  • Reported serum concentrations and developed profiles of toxicity related to drug concentrations for a number of psychotropic drugs in various patient populations